Transmyocardial Revascularization with Bone Marrow Aspirate (BMAC)

bone marrow aspirate with transmyocardial revascularization · Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Transmyocardial Revascularization with Bone Marrow Aspirate (BMAC), covering 2015-08-19 to 2015-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Transmyocardial Revascularization (TMR) With Bone Marrow Aspirate (BMAC) for Angina Reduction [NA]

See pricing